Literature DB >> 6976181

Folate catabolism in tumour-bearing rats and rats treated with methotrexate.

A M Saleh, A E Pheasant, J A Blair.   

Abstract

The metabolism of (2-14C) + (3',5',7,9-3H) folic acid was studied in normal rats, tumour-bearing rats and rats treated with methotrexate (MTX). The experiments were designed to investigate changes in the catabolism and folate. The breakdown of folate to scission products was again demonstrated to be a normal phenomenon. Catabolites excreted included p-acetamidobenzoate, p-acetamidobenzoyl-L-glutamate, 3H2O, urea and a number of pterins. The catabolic process was decreased in the presence of a tumour and increased by the administration of MTX. MTX also led to the excretion of 4 additional radioactive pterins not found in normal urine. The possible mechanisms of folate breakdown are discussed with reference to the point of action of MTX.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6976181      PMCID: PMC2010830          DOI: 10.1038/bjc.1981.256

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Metabolism of hepatomas of different growth rates in situ and during ischemia.

Authors:  G Weber; M Stubbs; H P Morris
Journal:  Cancer Res       Date:  1971-12       Impact factor: 12.701

2.  The isolation and characterization of dihydropteridine reductase from sheep liver.

Authors:  J E Craine; E S Hall; S Kaufman
Journal:  J Biol Chem       Date:  1972-10-10       Impact factor: 5.157

3.  Dihydropteridine reductase. Investigation of the specificity for quinoid dihydropteridine and the inhibition by 2,4-diaminopteridines.

Authors:  K E Lind
Journal:  Eur J Biochem       Date:  1972-02

4.  Identification of folic acid compounds in rat liver.

Authors:  Y S Shin; M A Williams; E L Stokstad
Journal:  Biochem Biophys Res Commun       Date:  1972-04-14       Impact factor: 3.575

5.  Pterins in human urine.

Authors:  T Fukushima; T Shiota
Journal:  J Biol Chem       Date:  1972-07-25       Impact factor: 5.157

6.  The characteristics of the membrane transport of amethopterin and the naturally occurring folates.

Authors:  I D Goldman
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

7.  On the specificity of labeling in tritiated folic acid.

Authors:  S F Zakrzewski; E A Evans; R F Phillips
Journal:  Anal Biochem       Date:  1970-07       Impact factor: 3.365

8.  Oxidative degradation of dihydrofolate and tetrahydrofolate.

Authors:  D Chippel; K G Scrimgeour
Journal:  Can J Biochem       Date:  1970-09

9.  Folate metabolism in the rat liver during regeneration after partial hepatectomy.

Authors:  B Barbiroli; C Bovina; B Tolomelli; M Marchetti
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

10.  Studies of folate compounds in nature. Folate compounds in rat kidney and red blood cells.

Authors:  Y S Shin; K U Buehring; E L Stokstad
Journal:  Arch Biochem Biophys       Date:  1974-07       Impact factor: 4.013

View more
  4 in total

1.  Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells.

Authors:  Yuxiang Zheng; Ting-Yu Lin; Gina Lee; Marcia N Paddock; Jessica Momb; Zhe Cheng; Qian Li; Dennis L Fei; Benjamin D Stein; Shivan Ramsamooj; Guoan Zhang; John Blenis; Lewis C Cantley
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

Authors:  J E Baggott; W H Vaughn; B B Hudson
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

3.  Metabolism of 5-methyltetrahydrofolate by rats bearing the Walker 256 carcinosarcoma.

Authors:  J C Kennelly; J A Blair; A E Pheasant
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

4.  Folate metabolism in man: the effect of malignant disease.

Authors:  A M Saleh; A E Pheasant; J A Blair; R N Allan; J Walters
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.